PODDInsulet
About Insulet
Insulet (NASDAQ:PODD) specializes in developing, manufacturing, and marketing innovative medical devices for people with insulin-dependent diabetes. Primarily known for its flagship product, the Omnipod Insulin Management System, Insulet aims to simplify diabetes management through its wearable, tubeless insulin pump technology. The company's projects revolve around enhancing the user experience, expanding global accessibility, and advancing diabetes technology to improve the lives of its users. With a commitment to innovation, Insulet is focused on continuing to grow its product portfolio, striving for advancements that can lead to better health outcomes and increased convenience for people living with diabetes worldwide.
What is PODD known for?
Snapshot
Public US
Ownership
2000
Year founded
2919
Employees
Acton, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
United States
Products and/or services of Insulet
- Omnipod Insulin Management System: A tubeless, waterproof insulin pump offering continuous insulin delivery, improving convenience and control over diabetes management.
- Omnipod DASH System: An innovative, touchscreen personal diabetes manager that communicates wirelessly with the waterproof Pod, offering modern diabetes management.
- Omnipod 5 Automated Insulin Delivery System: A smart system providing automated insulin delivery based on continuous glucose monitoring data, enhancing glucose control with less user input.
- Omnipod DISPLAY and VIEW Apps: Smartphone applications allowing users and caregivers to monitor insulin delivery and glucose levels remotely, promoting better diabetes management.
- myOmnipod Training App: An educational tool designed to help new users understand how to effectively use their Omnipod Insulin Management System through interactive guidance.
- Omnipod Horizon System: Under development, aiming to further advance the technology in automated insulin delivery systems for improved diabetes management outcomes.
Insulet executive team
- Ms. Flavia H. PeaseExecutive VP & CFO
- Mr. Eric BenjaminExecutive VP & COO
- Mr. John Wodick Kapples J.D.Senior VP & General Counsel
- Ms. Ashley A. McEvoyCEO, President & Director
- Mr. Amit GulianiSenior VP & CTO
- Ms. Clare TrachtmanVice President of Investor Relations
- Ms. Laetitia CousinSenior VP of Regulatory Affairs, Quality Assurance & Compliance
- Ms. Angela Geryak WiczekSenior Director of Corporate Communications
- Mr. Philip HildaleSenior Vice President of Sales & Customer Care
- Mr. Andrew IsaacsonSenior VP of Strategy & Corporate Development